Page 42 - Read Online

Dolan et al. Mini-invasive Surg 2021;5:3 I http://dx.doi.org/10.20517/2574-1225.2020.101 Page 7 of 8

professionals/physician_gls/pdf/nscl.pdf [Last accessed on 18 Dec 2020.]
4. Fernando HC, Landreneau RJ, Mandrekar SJ, et al. Thirty- and ninety-day outcomes after sublobar resection with and without
brachytherapy for non-small cell lung cancer: results from a multicenter phase III study. J Thorac Cardiovasc Surg 2011;142:1143-51.
5. Kent M, Landreneau R, Mandrekar S, et al. Segmentectomy versus wedge resection for non-small cell lung cancer in high-risk operable
patients. Ann Thorac Surg 2013;96:1747-54.
6. Sancheti MS, Melvan JN, Medbery RL, et al. Outcomes after surgery in high-risk patients with early stage lung cancer. Ann Thorac Surg
2016;101:1043-50.
7. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac
Surg 1995;60:615-22.
8. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal
surgical candidates. J Thorac Cardiovasc Surg 2005;129:639-44.
9. Zhong L, Sun S, Shi J, et al. Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation. J
Thorac Dis 2017;9:590-7.
10. Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with
more than 200 procedures. Radiology 2005;235:289-98.
11. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology
2007;243:268-75.
12. Lam A, Yoshida EJ, Bui K, Fernando D, Nelson K, Abi-Jaoudeh N. A national cancer database analysis of radiofrequency ablation versus
stereotactic body radiotherapy in early-stage non-small cell lung cancer. J Vasc Interv Radiol 2018;29:1211-7.
13. Zhao H, Steinke K. Long-term outcome following microwave ablation of early-stage non-small cell lung cancer. J Med Imaging Radiat
Oncol 2020;64:787-93.
14. Yuan Z, Wang Y, Zhang J, Zheng J, Li W. A meta-analysis of clinical outcomes after radiofrequency ablation and microwave ablation for
lung cancer and pulmonary metastases. J Am Coll Radiol 2019;16:302-14.
15. Inoue M, Nakatsuka S, Jinzaki M. Cryoablation of early-stage primary lung cancer. Biomed Res Int 2014;2014:521691.
16. Zhang YS, Niu LZ, Zhan K, et al. Percutaneous imaging-guided cryoablation for lung cancer. J Thorac Dis 2016;8:S705-9.
17. Yamauchi Y, Izumi Y, Hashimoto K, et al. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung
cancer. PLoS One 2012;7:e33223.
18. Moore W, Talati R, Bhattacharji P, Bilfinger T. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically
inoperable patients. J Vasc Interv Radiol 2015;26:312-9.
19. Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell
lung cancer. J Am Coll Surg 2010;211:68-72.
20. Videtic GMM, Donington J, Giuliani M, et al. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive
summary of an ASTRO evidence-based guideline. Pract Radiat Oncol 2017;7:295-301.
21. Videtic GM, Hu C, Singh AK, et al. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically
inoperable patients with stage i peripheral non-small cell lung cancer: NRG oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol
Biol Phys 2015;93:757-64.
22. Videtic GM, Paulus R, Singh AK, et al. Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2
study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell
lung cancer. Int J Radiat Oncol Biol Phys 2019;103:1077-84.
23. Bi N, Shedden K, Zheng X, Kong FS. Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy
in inoperable stage i non-small cell lung cancer: a systemic review and pooled analysis. Int J Radiat Oncol Biol Phys 2016;95:1378-90.
24. Ager BJ, Wells SM, Gruhl JD, et al. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small
cell lung cancer. Lung Cancer 2019;138:6-12.
25. Chi A, Fang W, Sun Y, Wen S. Comparison of long-term survival of patients with early-stage non-small cell lung cancer after surgery vs
stereotactic body radiotherapy. JAMA Netw Open 2019;2:e1915724.
26. Jensik RJ, Faber LP, Milloy FJ, Monson DO. Segmental resection for lung cancer. A fifteen-year experience. J Thorac Cardiovasc Surg
1973;66:563-72.
27. Altorki NK, Yip R, Hanaoka T, et al; I-ELCAP investigators. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung
cancer in solid nodules. J Thorac Cardiovasc Surg 2014;147:754-62.
28. Ijsseldijk MA, Shoni M, Siegert C, et al. Oncologic outcomes of surgery versus sbrt for non-small-cell lung carcinoma: a systematic
review and meta-analysis. Clin Lung Cancer 2020:S1525-7304(20)30140-6.
29. Hou B, Deng XF, Zhou D, Liu QX, Dai JG. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with
stage I non-small cell lung cancer: a meta-analysis. Ther Adv Respir Dis 2016;10:435-43.
30. Suzuki K, Saji H, Aokage K, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J
Thorac Cardiovasc Surg 2019;158:895-907.
31. Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-
small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med
2018;6:915-24.
32. Stamatis G, Leschber G, Schwarz B, et al. Perioperative course and quality of life in a prospective randomized multicenter phase III trial,
comparing standard lobectomy versus anatomical segmentectomy in patients with non-small cell lung cancer up to 2 cm, stage IA (7th